Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M263Revenue (TTM) $M7.8Net Margin (%)-686.1Altman Z-Score-4.7
Enterprise Value $M285EPS (TTM) $-0.7Operating Margin %-969.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-928.5Higher ROA y-yN
Price/Book23.110-y EBITDA Growth Rate %32.6Quick Ratio2.4Cash flow > EarningsY
Price/Sales28.85-y EBITDA Growth Rate %45.2Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-67.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-288.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M95.0ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-01-20Buy300,000$2.3517.87view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2016-01-20Sell300,000$2.3517.87view
FARRELL STEPHEN CDirector 2015-11-06Buy50,000$3.83-27.68view
Russell Angus C.Director 2015-11-06Buy50,000$3.83-27.68view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2015-11-06Sell100,000$3.83-27.68view
ANDREWS DEBORAH JDirector 2015-08-26Buy2,000$2.82-1.77view
Cartt Stephen LaHueDirector 2015-08-18Buy75,000$2.8-1.07view
Russell Angus C.Director 2014-12-12Sell0$0-1.07view
Cartt Stephen LaHueDirector 2014-11-04Sell0$0-1.07view
FARRELL STEPHEN CDirector 2014-10-08Buy32,050$3.12-11.22view

Quarterly/Annual Reports about BTX:

News about BTX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

More From Other Websites
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure May 26 2016
BioTime, Inc. :BTX-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 May 26 2016
BioTime to Present at Two Upcoming Investor Conferences May 20 2016
BioTime to Present at Two Upcoming Investor Conferences May 20 2016
BIOTIME INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial... May 19 2016
BIOTIME INC Financials May 19 2016
This may be the next central bank to adopt negative rates May 11 2016
BIOTIME INC Files SEC form 8-K, Results of Operations and Financial Condition May 10 2016
BIOTIME INC Files SEC form 10-Q, Quarterly Report May 10 2016
BioTime, Inc. Reports First Quarter Results and Recent Corporate Accomplishments May 10 2016
BioTime, Inc. Reports First Quarter Results and Recent Corporate Accomplishments May 10 2016
ReCyte Therapeutics, a BioTime Subsidiary, Announces Peer-Reviewed Publication on Pericyte-Like... May 06 2016
BioTime Co-CEO Dr. Michael West Presents at Biomedical Innovation for Healthy Longevity,... Apr 26 2016
BioTime Co-CEO Dr. Michael West Presents at Biomedical Innovation for Healthy Longevity,... Apr 26 2016
LifeMap Solutions Launches Full-Service Mobile Health App Design & Development to Meet the Needs of... Apr 25 2016
LifeMap Solutions Launches Full-Service Mobile Health App Design & Development to Meet the Needs of... Apr 25 2016
ETF’s with exposure to BioTime, Inc. : April 19, 2016 Apr 19 2016
BIOTIME INC Files SEC form 8-K, Change in Directors or Principal Officers Apr 15 2016
BioTime Co-CEO Dr. Michael West to Present at Stem Cells in Drug Discovery 2016 in Cambridge, UK Apr 05 2016
BioTime Co-CEO Dr. Michael West to Present at Stem Cells in Drug Discovery 2016 in Cambridge, UK Apr 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)